Recent Advances in the Treatment of HIV/HBV and HIV/HCV Co-Infection

Title:Recent Advances in the Treatment of HIV/HBV and HIV/HCV Co-Infection

Volume: 12 Issue: 9

Author(s): A. Masgala, S. Bonovas and G. K. Nikolopoulos

Affiliation:

Keywords: HIV, HBV, HCV, co-infection, treatment, drugs, hepatitis B, hepatocellular carcinoma, adefovir, lamivudine, entecavir

Abstract: Concurrent infection with hepatitis B virus (HBV) and hepatitis C virus (HCV) in patients positive for human immunodeficiency virus (HIV) is relatively common. The treatment of co-infected individuals is rather complex because the anti-viral therapy may be associated with drug-resistance, hepatotoxicity and lack of response. Herein, we present a summary of the available compounds and the recent recommendations concerning the therapeutic management of HIV/HBV and HIV/HCV co-infections.

Cite this article as:

Masgala A., Bonovas S. and K. Nikolopoulos G., Recent Advances in the Treatment of HIV/HBV and HIV/HCV Co-Infection, Mini-Reviews in Medicinal Chemistry 2012; 12 (9) . https://dx.doi.org/10.2174/138955712800959062